Predictive Factors of Stent Patency in Iliofemoral Venous Diseases in a Multicentre Cohort Study

医学 血栓后综合征 中止 外科 深静脉 血栓形成 支架
作者
O. Espitia,Frédéric Douane,Jeanne Hersant,Fabrice Abbadie,Jonathan Sobocinski,Jean-François Heautot,Annaïg Miossec,François-Xavier Lapébie,Olivier Hartung
出处
期刊:European Journal of Vascular and Endovascular Surgery [Elsevier BV]
卷期号:65 (4): 564-572 被引量:6
标识
DOI:10.1016/j.ejvs.2023.01.005
摘要

This study assessed primary stent patency predictive factors in three groups of patients with history of lower limb (LL) vein thrombosis: non-thrombotic iliac vein lesion (NIVL), acute deep vein thrombosis (aDVT), and post-thrombotic syndrome (PTS).Consecutive patients from January 2014 to December 2020 with history of LL vein stenting from seven hospitals were included. All patients received an iliac or common femoral venous stent and had at least a six month follow up available with stent imaging. Anticoagulant and antiplatelet therapy strategies employed after venous stenting are reported and compared between groups.This study included 377 patients: 134 NIVL, 55 aDVT, and 188 PTS. Primary patency was statistically significantly higher in the NIVL group (99.3%) compared with the PTS group (68.6%) (p < .001) and the aDVT group (83.6%) (p = .002). PTS patients received a statistically significantly greater number of stents (p < .001) and had more stents below the inguinal ligament (p < .001). Median follow up was 28.8 months (IQR 16, 47). Discontinuation of antiplatelet therapy at the last assessment was 83.6% for NIVL, 100% for aDVT, and 95.7% for the PTS group (p < .001). Discontinuation of anticoagulation therapy at the last assessment was 93.2% for NIVL, 25.0% for aDVT, and 70.3% for the PTS group (p < .001). The only predictor of worse primary patency in the aDVT group was long term anticoagulation before stenting.Patients with NIVL have better primary patency after venous stenting than patients with venous thrombotic disorders. Long term anticoagulation before stenting was the only factor associated with poorer primary patency in patients with aDVT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
闾丘剑封发布了新的文献求助10
刚刚
可爱的函函应助小晓采纳,获得10
3秒前
Owen应助SciEngineerX采纳,获得10
3秒前
幸福大白发布了新的文献求助30
4秒前
内向寒云完成签到,获得积分10
6秒前
CipherSage应助DC采纳,获得10
6秒前
淡然的花卷完成签到,获得积分10
7秒前
9秒前
无语的不言完成签到,获得积分20
10秒前
10秒前
慕青应助lzx采纳,获得10
11秒前
11秒前
11秒前
Orange应助欧耶采纳,获得10
12秒前
12秒前
12秒前
yyyyyyy完成签到,获得积分10
14秒前
SciEngineerX发布了新的文献求助10
15秒前
木木完成签到,获得积分10
15秒前
啧啧啧发布了新的文献求助10
16秒前
研友_VZG7GZ应助33采纳,获得30
16秒前
yyyyyyy发布了新的文献求助10
17秒前
17秒前
禹代秋发布了新的文献求助10
18秒前
杰2580发布了新的文献求助10
19秒前
20秒前
20秒前
幸福大白发布了新的文献求助30
20秒前
量子星尘发布了新的文献求助10
21秒前
禹代秋完成签到,获得积分10
21秒前
LAVINE完成签到 ,获得积分10
22秒前
欧耶发布了新的文献求助10
24秒前
啧啧啧完成签到,获得积分10
25秒前
高手中的糕手完成签到,获得积分10
27秒前
gsj发布了新的文献求助10
32秒前
优雅翎完成签到,获得积分10
33秒前
喜喵喵发布了新的文献求助10
34秒前
35秒前
清脆凡阳发布了新的文献求助10
35秒前
张雯思给张雯思的求助进行了留言
36秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989450
求助须知:如何正确求助?哪些是违规求助? 3531621
关于积分的说明 11254315
捐赠科研通 3270207
什么是DOI,文献DOI怎么找? 1804928
邀请新用户注册赠送积分活动 882105
科研通“疑难数据库(出版商)”最低求助积分说明 809176